PMI’s Latest Clinical Results: Findings Add to Extensive Evidence Pack
Likely the first ever clinical study of this magnitude to directly assess ri...

2018-06-17

文传商讯
Boehringer Ingelheim starts clinical study on interchangeability betwee
First patient enrolled into VOLTAIRE-X; an interchangeability study designed...

2017-07-31

文传商讯
Boehringer Ingelheim presents phase III results demonstrating clinical
Pivotal Phase III study results for biosimilar candidate BI 695501 will be p...

2017-06-16

文传商讯
Latest clinical research confirms that IQOS reduces smoker exposure to
Studies conducted to date clearly indicate that IQOS is likely to present le...

2017-03-29

文传商讯
Boehringer Ingelheim bevacizumab biosimilar candidate demonstrates bioe
Phase I study shows bioequivalence between BI 695502 and Avastin® (bevac...

2016-11-18

文传商讯
Patient enrolment completed for RE-DUAL PCI study assessing dabigatran
Over 2,700 atrial fibrillation (AF) patients undergoing a percutaneous coron...

2016-11-16

文传商讯
SES Reaches 2.81 Million TV Homes in Nigeria, New Study Reveals
Satellite growth and accessibility will accelerate digital broadcasting in N...

2016-06-24

文传商讯
SES Expands Its Reach to Two Million TV Homes in Ghana
SES reaches two million TV homes in Ghana, an overall growth of 18% since 20...

2016-06-01

文传商讯
Boehringer Ingelheim launches RE-COVERY DVT/PE TM: global observational
First patient enrolled in RE-COVERY DVT/PE™Involving 14,000 patients w...

2016-03-24

文传商讯
Nearly 14% of Deals Covered by M&A Insurance Resulted in a Claim, Accor
Global Claims Data Study Spans Policies for approximately 1,000 Deals, Worth...

2016-02-26

文传商讯